Venrock Healthcare Capital Partners II, L.P.'s Net Worth
$618 Million
Who is Venrock Healthcare Capital Partners II, L.P.?
Venrock Healthcare Capital Partners II, L.P. has an estimated net worth of $618 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Shockwave Medical, Inc., KalVista Pharmaceuticals, Inc., Altimmune, Inc., Unum Therapeutics Inc., Bellerophon Therapeutics, Inc., ARCA biopharma, Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Avalanche Biotechnologies, Inc..
SEC CIK
Venrock Healthcare Capital Partners II, L.P.'s CIK is 0001602264
Past Insider Trading and Trends
2022 was Venrock Healthcare Capital Partners II, L.P.'s most active year for acquiring shares with 46 total transactions. Venrock Healthcare Capital Partners II, L.P.'s most active month to acquire stocks was the month of May. 2019 was Venrock Healthcare Capital Partners II, L.P.'s most active year for disposing of shares, totalling 4 transactions. Venrock Healthcare Capital Partners II, L.P.'s most active month to dispose stocks was the month of September. 2019 saw Venrock Healthcare Capital Partners II, L.P. paying a total of $13,899,999.90 for 4,786,899 shares, this is the most they've acquired in one year. In 2019 Venrock Healthcare Capital Partners II, L.P. cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.06% | 400K |
$34.50 | $13,800,000.00 | 4.02M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Shockwave Medical, Inc. (SWAV) Snapshot price: $236.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.12M |
—
|
—
| 2.12M |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.46% | -500.00K |
$28.75 | -$14,375,000.00 | 1.54M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Altimmune, Inc. (ALT) Snapshot price: $10.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -1.00M |
—
|
—
| 3.5M |
Feb 25
| |||
Form 4
| +50.00% | 1.5M |
$7.54 | $11,310,000.00 | 4.5M |
Jun 15
| |||
Form 4
| +76.85% | 1.3M |
$8.74 | $11,395,493.13 | 3M |
May 26 - May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unum Therapeutics Inc. (COGT) Snapshot price: $6.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.55% | 451K |
$2.52 | $1,137,120.00 | 4.36M |
Aug 14 - Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |